DatasetName,DPM1_S(21) DPM1_S(3) DPM1_S(435) DPM1_S(7),DPM1_S(9)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.3761444912539558,0.4134011950408892
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.4363848804440916,0.5344507646581003
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,0.416346722481383
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5731819252874064,0.6659768727852087
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.668962257874694
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.4865056831780682,0.5411498444187445
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5081826918338384,0.5758591085020391
FSO2013_Ratio M/L normalized Rep1___1,0.5718639639162894,0.6619998947669258
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,0.4995626715755804
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,,0.4787000942305105
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.485172647059793,0.5085071297586069
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,0.4077575070007526
PG2020_Intensity 8h_C,,0.6078876665700421
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.4995082112422251,0.2989513788217697
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.7893910775802875
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.4321460132798627
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.48248679298097613,0.519970989570475
WZ2023_Pu_005_10min,,0.5182902066832261
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.4585920906990223,0.619931763892711
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.5168019986974208,0.8545258872880205
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.6098006164998339
FR2021_Norm.Intensity.B,,0.7220648824522031
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,0.7897125411470564
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,0.5785571301022243
CR2017_Ratio Replicate 1.3,,0.5609858716320814
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5916766606645266
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.4865211578887218,0.5272219929738116
HS2024_3_B_N1,0.5056110065404542,0.5043539751303245
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.3973853452290087
CK2022_11 40-1,0.454721323581586,0.6214579969848374
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.4765476802762868,
FSO2013_Ratio H/L normalized Rep2,,0.5706051340156546
WZ2023_Pu_005_20min,,0.4141996116311021
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.6245798205401542
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,0.4238518261445216
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.4723594957979983
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.4819478017593517,0.6776085146124032
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,0.5904685732859013
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,0.7056782126117059
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.49641268963781704,0.7142332463528237
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.451707284224925,0.5104583928336945
CK2022_1 200-1,0.47623609602633704,0.6463477891445601
PG2020_Intensity Mock_10h_D,,0.727152830013827
SR2019_MCF10A_Biol_repl_2,,0.3702032689653526
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.4913492227220021,0.3469596571452653
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,0.7521767776494284
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5488490863606331
PG2020_Intensity 2h_C,0.49793493274234346,0.6418193514802631
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.47416462542085736,0.4895056256665318
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.485060815860712,0.3781096375898395
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,0.4406589854421872
HS2024_5_PD_T1,,0.5589775340863242
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,0.45976974399443393,0.6284836097716423
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.5248488300792942
YA2020_Reporter_intensity_Cancer_No.5,0.47029934198684076,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,0.5877062034322814
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,0.460906810584837,
HS2024_3_B_T1,0.4978798314004239,0.4790424774669641
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.4486170210204163
SR2019_Hs578T_Biol_repl_3,,0.4901850133836978
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.7616396800344231
HS2024_8_I_T3,,0.3107886908001007
CF2017_EOC 3,0.5276148728173182,0.8775468830775393
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.48797314743308673,0.1403247277080043
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.4730491589159575
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.45728130338621664,0.6334453937684943
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.43789634751374207,0.5503564491454689
KS2014_Intensity N3,0.5422926375970534,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,0.4958357682206331
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,0.535853769784782
RAM2015_Log2 A,0.4996705833209067,0.5740469356390975
HS2024_8_PD_T1,,0.3051938649948952
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5362687126360177,0.8473139131048254
KS2014_Intensity E15_2,0.46053183969177913,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.4085446615618665,0.5284831580936852
HS2024_7_I_T1,,0.430244372639228
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,0.3996980184782172
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.4644543610034314,0.5644064838747644
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.4803003258005422,0.5217874490557033
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,0.4782154002482975
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,0.5192682621241471,0.634371632961139
KBE2022_Log2_Ex_27_T,0.49863789005725256,0.5778386584018215
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.4078715352632611
FSO2013_Ratio M/L normalized Rep2,0.41329245508068435,0.5860583183575507
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,0.338659847733644
CK2022_14 40-1,0.4545679048108169,0.6120569793399321
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.7363017864381871
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.503510511613133
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,0.4359399956181814
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5290726800640371
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,0.5552336064806402
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,,0.632428034696967
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.44491563434123416,0.6694407077922105
CK2022_12 200-1,0.45054977284537373,0.6752555526778036
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,0.2577505641161285
AH2018_TMTMS2_2_N,,0.3488972692903827
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.48429487627557477,0.5194212853088258
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.5465849290477016,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.5650337267065828
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5347078760796705,0.8541732876420499
CK2022_14 200-1,0.45676532971202277,0.6480766139452998
SR2019_Hs578T_Biol_repl_1,,0.3486447845744528
RB2022_7_PostSprint,,0.2698457839692654
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.4988656216657272,0.6922629574868385
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.5678968327885874
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.45040427879489514,0.5272408796081934
GF2025_P1_Adh,,0.4789719221496471
GF2025_P1_Sph,,0.6423804088985019
EJN2021_5_Ex_Basal,,0.5907752752447714
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.4725314939780578
CF2017_EOC 1,,0.7855064917416922
CK2022_3 200-1,0.475472841767238,0.6413361831711436
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,0.3556940437787766
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5018861925831583,0.2123780981009185
HS2024_5_B_T1,,0.4398640941415176
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.4585293646870889,0.5526534299513874
RB2022_6_PreStrength,,
CK2022_2 40-1,0.4595495171726065,0.6349488411077434
RB2022_1_PostSprint,,
CK2022_4 200-1,0.47403560190033456,0.6496797076349826
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.4364934517118101,0.5501612183187339
AR2021_ALG 1 μM,,0.6096527174628269
HS2024_4_B_T1,,0.4985285310764042
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,0.5854300179743247
EJN2021_1_Rest_Basal,,0.5677086653885122
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.4780261208747864
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.3477368337749118
CK2022_9 16-1,0.4554721470328836,0.5752088725795931
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.45289652284584053,0.6440922956434407
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.7209571120199307
CK2022_16 16-1,0.4544961348516273,0.5381882770105432
FS2019_db/db3,,
CK2022_15 40-1,0.4559951513563937,0.614209380217303
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.4692677956999085
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.4843560038188649,0.5456765015336608
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.5265270075334876,0.5401081369323667
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.4827697944299639,0.4933223091003392
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,0.49980234969030246,0.5875080786521469
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,0.4572264553027171
RB2022_7_PreStrength,,0.4820668526307985
YA2020_Reporter_intensity_Normal_No.4,0.4649675882050662,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.7246634693116224
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.44845282452583934,0.5870379309907744
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.48552785568673024,0.5107057100909673
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.48884402395565124,0.3950822585936084
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4747507411697514,0.4185609415599031
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5492837204527796
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.4592165539010111,0.6198543224966256
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.4311761440101769,0.7106856685228733
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.48508517093778686,0.4089044691591603
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,0.6656006845171608
AH2018_TMTMS2_3_X,,0.3509028462715784
GF2025_P3_Adh,,0.6538698512040111
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.3643397370272211
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5214781073564589,0.7211473858629427
KBE2022_Log2_Ex_19_U,0.49468982129642436,0.4971036276512572
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.4791268818714602,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.4130133264466671,0.583545073653431
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,0.3374018400518067
RB2022_7_RecoverySprint,,0.5071883033986817
YA2020_Reporter_intensity_Normal_No.3,0.46811555395488424,
HS2024_8_B_T2,,0.4983384481997214
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,0.6902165942895196
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.544722800837462,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.46552405212963643,
SR2019_MCF7_Biol_repl_1,,0.5395728155488398
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5189345736087403,0.6225127488584379
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.5554140673254285
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.4691146816541444
AR2021_KD 72h,,0.4706438913395607
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.49230667138657147,0.5511331534879185
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,0.49549734924759115,0.5077235584729514
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.4780835909851856,0.4845310088902972
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.49133364615728464,0.7113048667040478
CF2017_OSE 29,0.5461799478412378,0.8385245585159751
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.4654581113514546,0.4489228789353854
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,0.7209228150453402
FSO2013_Ratio H/M normalized Rep1___1,,0.5665703801204187
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.45888271817467674,0.6275309871599839
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.3797908671609625
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.6794420419900725
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.508562118959582,0.5172378269541877
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.4364099768029844,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.4706963440521613
CK2022_7 200-1,0.4730894348617068,0.6151215253951082
CK2022_5 200-1,0.4769031513854451,0.6107879274844291
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5720876941084514
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,0.444677147127648
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.4849321906614966,0.5290417880824626
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,0.5907412684548523
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5581100281050202
CK2022_4 16-1,0.4559484757542269,0.5224107355960546
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.5489219495669408
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.6134335189718265
FSO2013_Ratio H/L normalized Rep3,,0.5377798171621673
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.4757629144856831,0.4838275385396506
KBE2022_Log2_Ex_9_T,0.48970706800367325,0.5281028240714278
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.6035201861561519
WZ2023_Pe_025_20min,,0.407983417045238
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,0.5791036330241556
AH2018_TMTMS2_3_N,,0.3646886269248617
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.4852060620084615,0.4532179304153957
WZ2023_Su_005_30min,,0.2980880394791155
SR2019_HCC1419_Biol_repl_4,,0.6435263460589868
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.4990863404495894
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.3954597602601197
WZ2023_Su_025_10min,,0.4999350713538774
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.426133428943026
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5261032736388376,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.4751311058058144,0.5748155295340407
LY2019_P7+,0.4569374513148156,0.2905427381639129
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,,
PG2020_Intensity 4h_C,0.48873602184396037,0.6800282923914516
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.48177500465798395,0.5148387354715251
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,,0.6037489073667132
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.47890498640347495,0.4916997810962624
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5275546915227534,0.3967981289386523
KBE2022_Log2_Ex_6_U,,0.5079633913429489
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.49002159685501195,0.5250077750064562
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.46113412851603364,0.648211282219378
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,,0.6905917373556871
CK2022_6 200-1,0.47713802149505447,0.6155353953724158
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.4347313943764487
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.47840367469499934,0.6248417601295063
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,0.4257755608668136
HS2024_3_B_T3,,0.4300086696269841
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.5891864372065205
PG2020_Intensity 2h_D,0.5092370366952808,0.6950003567289442
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.4724149070277355,0.6178459056063305
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5210960517637586
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.486998616128833,0.4802742447232986
KBE2022_Log2_Ex_29_T,0.4932207618619503,0.538962175384006
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.5450754705854004
FR2021_Intensity.M,,0.6902165942895196
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5346773625192918,0.8459999913123388
PG2020_Intensity CT_C,0.4910878812436942,0.690434523226509
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.4650948726008306,0.505330577743702
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.4526251568331794
HS2024_8_PD_T2,,0.3916564732745353
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,0.6890716099522172
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5129718353156654,0.4994526579292647
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5333755564468099
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.4235394578217243
CR2017_Ratio Replicate 2.3,0.4771462138673594,0.4724227160295852
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.570760397755862
YA2020_Reporter_intensity_Normal_No.2,0.46300168789251456,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.4740980879472149,0.4656477153558206
HS2024_3_PD_T3,0.46633970294580596,0.5179986662797967
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,0.7129436806630415
RAM2015_Log2 C,,0.8257553511017034
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4818953476989887,0.4895885405392582
CK2022_2 16-1,0.4491176942595716,0.5234068321242122
RAM2015_Log2 B,0.4907836526484506,0.5567861218216582
YP2020_Intensity C10_R1_mult_log2,,0.4543871892297842
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.6020453756009082
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.48426092280820277,0.5949488525169334
PG2020_Intensity Mock_10h_B,,0.6171232873566495
WZ2023_Su_025_30min,,0.3970260595593671
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,0.6015469398281023
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5052372967035424,0.4778272443882726
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,0.2887588966878276
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.42526815646345095,0.6628631449741376
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.4779020763901036
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,0.4031725699279528
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.4753891785377601,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,0.3199334933704859
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.4559884846162877
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.6207715354922455
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.5416170700809673
SR2019_BT549_Biol_repl_1,,0.5563316899161276
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5847034361290195
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,0.6718725364414602
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.47306116335308607,
GF2025_P3_Sph,,0.6520283743685106
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5377205087315295
ZQ2022_N1,,
LY2019_P6-,0.48843780039958196,0.6315570704104693
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.47560319427954045,0.5211835088397554
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.4570403745631777,0.6255966606879804
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.6807349432931423
SR2019_BT549_Biol_repl_2,,0.5939340241799898
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.3157603299451513
HS2024_5_PD_T2,0.5411127037992991,0.5493574976961103
WZ2023_Su_025_20min,,0.4212404021062359
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,0.4494704958408784
LY2019_P8-,0.5871724094889308,0.434683645158295
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5802363255401385
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.45282286885459544,0.6170541091093682
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.1621337094040328
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.4520541769242577,0.644839848876098
EJN2021_4_Ex_Ins,,0.5853128928857544
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.5557937753862494
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.4554631493898509,0.6183561312530623
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.49170811360773836,0.5368913477210947
LY2019_P3-,0.4939715773466839,0.7345585499648136
FR2021_Intensity.A,,0.696204802066822
EJN2021_3_Ex_Ins,,0.5473663045934124
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,
HS2024_8_PD_T3,,0.3342997695047451
EJN2021_3_Ex_Basal,,0.5574522326590632
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.48293726988461033,0.6315457932413725
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.413340563390536
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.5534109300779984
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,0.6897677724582335
HS2024_5_B_N1,0.519609549129664,0.5324936021180824
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.3788023973257252
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.5102735117571953,0.4903928246543633
RB2022_3_RecoveryStrength,,0.373515245942099
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,0.5405336695746161,0.7441247530078119
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.3295180026473708
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.5543932016893712
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,0.5043162808829372
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.4597604362566008,0.5209441407882576
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5365584528629004,0.8299498437789259
LY2019_P2-,0.40350051715358237,0.3636370284841912
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,,0.3819645721446554
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5015017085956034,0.3376887767308118
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.45751132246692455,0.6321414037763944
SR2019_MCF10A_Biol_repl_4,,0.4757581530038984
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5362440947873662,0.8396116538673225
HS2024_5_B_T2,,0.4030367560163282
HS2024_6_I_T1,,
HS2024_5_B_T3,,0.4043318409808211
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5018900294792233,0.5774905277413258
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,0.6629074124322736
FR2021_Intensity.N,,0.6897255399617617
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,0.49898946594581023,0.573608881669482
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.4943678302399942
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.4693687945710536,0.5371410544754448
CK2022_9 200-1,0.4539139367548313,0.6691154212527614
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.44915277677277865,0.665896057192016
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.4008910144359937
RBK2021_1332T Late,,
LY2019_P1-,0.5150456296618235,0.4516574056092104
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.4688822313036773
HS2024_3_I_T3,0.5024954989812005,0.3519018576513747
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.4710096919896167,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.5995062455763127
YP2020_Intensity P10_R2_mult_log2,,0.4802326315948659
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.5032276527819444
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,0.5128233599791998
HS2024_5_I_T3,,0.5053163672076153
KS2014_Intensity N1,0.537271204516382,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.48811047013352565,0.5326903396583954
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.48182089770850833,0.6424571980166474
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5483685935743521,0.5761324588107946
HS2024_5_I_N1,0.5544352669700279,0.4767110875534039
HS2024_6_I_N1,0.4699497041574868,0.5298021011116079
AR2021_KD 48h,,0.526848913086431
FR2021_Intensity.B,,0.7225766285495274
RB2022_3_PreEndurance,,0.324221940732408
HS2024_5_I_T1,,0.8399006217448839
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.5279872066084274
KBE2022_Log2_Ex_29_U,0.4938883016751554,0.5389530211094512
HS2024_7_B_T1,,0.5266820144596376
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.4552497978110025,0.6475475940515063
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.482879559378986,0.5258344438386335
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5871750646194418,0.3976337598043228
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.48351524375132693,0.6512206272543531
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.4143031867523561
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.5688042130297782
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.5576288919429371
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,0.49364217964860296,0.4041722560818186
YA2020_Reporter_intensity_Cancer_No.3,0.4725692851522124,
KBE2022_Log2_Ex_44_U,0.4812974574300235,0.5261612949171763
WZ2023_Pe_010_20min,,0.5013092946048882
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.4377275137845929,
FSO2013_Ratio H/M normalized Rep3___1,,0.4708359867910796
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.4696148079752335,0.5377904698355973
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.2883445703297833
PG2020_Intensity 6h_C,,0.6830226677374983
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.371863114569883
CK2022_15 16-1,0.4480745860986407,0.5318620698005289
CK2022_3 16-1,0.43969676001981567,0.5084959393002788
LY2019_P4-,0.4584464387573598,0.5773216350689007
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.47667778595451904,0.589588125394451
GF2025_P8_Adh,,0.6610027496153864
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,0.69857844376447
GF2025_P5_Sph,,0.6087671154869203
CK2022_10 16-1,0.44174163543338907,0.5691472782739634
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,0.43672636286435
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,,0.5695084397063658
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5363733083422829,0.8513104289067029
AR2021_L41 10 μM,,0.3831731541145235
CF2017_EOC 2,0.5281360637019992,0.8723200398612896
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,0.3257929849568692
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.473759897075168,0.4865713642404693
CK2022_6 16-1,0.4328481085012662,0.5434401830873871
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.3814679414089379
AR2021_L41 1 μM,,0.5058608332954245
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.3674723190535292
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.47668912750580084,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.48609028589491005,0.5248915425735174
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.5148606880498243
HS2024_7_B_T2,,0.4689105708546377
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.4632436288088835,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,,0.4651414034727641
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.379507872892196,0.4139704690462846
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,0.4213745401153774
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.521057707028789,0.8152984940140866
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.5272062612811916
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.4606131644484988,0.6237864907622142
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.45713117513868734,0.6153401884187188
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,0.4562026603775503,0.6225861316144575
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,0.5558753141708364,0.4207369685693357
GF2025_P5_Adh,,0.6032678656247777
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5391575358248667
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.4684156825997112,0.4679691069225064
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.45411986306604174,0.5411979090180444
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.4466193863856298
PG2020_Intensity CT_B,,0.6879798244641832
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,0.4676122281281639,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.6308585219634355
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.4792229859926985,0.5324408467431477
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,0.7056782126117059
CK2022_14 16-1,0.45479561286696046,0.5319395298177173
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.4787733996252842,0.6085373620766753
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,0.4033064828471345
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,,0.3851960341389046
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.5738762369183489
HS2024_6_I_N2,0.494586088206602,0.5688302279115566
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.854150937128878
HS2024_4_I_T3,0.49546741244610293,0.7486166459449757
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,0.2923545969127124
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,0.8858388493726927
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.4949943140945537,0.6931887452240335
SR2019_HCC1419_Biol_repl_3,,0.6673766751517519
KBE2022_Log2_Ex_14_T,0.4811557098673681,0.5174863018228844
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.47067658614730323,0.7134391087860255
HS2024_5_I_N2,0.5520983147595255,0.5644925485524528
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
